About Index Trending news
Analyze
Pricing
Galectin Therapeutics

Galectin Therapeutics

Galectin Therapeutics

Galectin Therapeutics Inc (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins

Elsewhere

Twitter followers

10 Feb 2010
$489,000
Grant
12 Feb 2009
$1,800,000
Venture capital (Series B)